JAMP TELMISARTAN-HCT recall in Canada: higher dosage than labelled
In plain language
This recall involves JAMP TELMISARTAN-HCT tablets sold in Canada. It's being recalled because affected lots may contain a higher dosage than labelled. Consult your healthcare provider before making any changes to your medication.
What to do
- Consult your healthcare provider prior to discontinuing use.
- Verify if your product is affected by checking the lot number.
- Contact JAMP Pharma Corporation if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP TELMISARTAN-HCT
Lot: EG22TCJ001
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: EG22TCJ001
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves JAMP TELMISARTAN-HCT tablets sold in Canada. It's being recalled because affected lots may contain a higher dosage than labelled. Consult your healthcare provider before making any changes to your medication.
What should consumers do?
Consult your healthcare provider prior to discontinuing use. Verify if your product is affected by checking the lot number. Contact JAMP Pharma Corporation if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on January 24, 2024.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves JAMP TELMISARTAN-HCT tablets sold in Canada. It's being recalled because affected lots may contain a higher dosage than labelled. Consult your healthcare provider before making any changes to your medication.